Analysts expect Roivant Sciences Ltd. to report revenue of 3.95 M for Q2 26, against a range of 3.77 M to 4.14 M. The most recent reported quarter, Q1 26, came in at 1.44 M, a 28.0% miss against the 2.00 M consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.47 M | 9.02 M | 7.57 M | 2.17 M | 1.57 M | 2.00 M | 2.52 M | 1.44 M | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 47.19 M | 4.98 M | 57.74 M | 8.15 M | 5.79 M | 5.72 M | 3.82 M | 2.12 M | 4.14 M | 12.73 M | 36.19 M | 52.97 M | 45.61 M | 72.57 M | 133.10 M | 211.83 M | |||||||||||
| Low Estimate | 38.88 M | 4.41 M | 54.11 M | 6.93 M | 5.21 M | 5.13 M | 3.29 M | 1.88 M | 3.77 M | 10.99 M | 31.89 M | 49.61 M | 38.26 M | 60.47 M | 120.10 M | 195.41 M | |||||||||||
| Consensus Estimate | 43.04 M | 4.70 M | 55.92 M | 7.54 M | 5.50 M | 5.43 M | 3.55 M | 2.00 M | 3.95 M | 11.86 M | 34.04 M | 51.29 M | 41.94 M | 66.52 M | 126.60 M | 203.62 M |
Analysts expect Roivant Sciences Ltd. to report earnings per share of -0.35 for Q2 26, against a range of -0.36 to -0.34. The most recent reported quarter, Q1 26, came in at -0.33, a 13.8% miss against the -0.29 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.31 | 0.23 | -0.29 | -0.25 | -0.20 | -0.17 | 0.28 | -0.33 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -0.23 | -0.24 | -0.24 | -0.25 | -0.29 | -0.26 | -0.28 | -0.27 | -0.34 | -0.36 | -0.34 | -0.33 | -0.33 | -0.34 | -0.35 | -0.19 | |||||||||||
| Low Estimate | -0.25 | -0.28 | -0.26 | -0.27 | -0.33 | -0.30 | -0.32 | -0.31 | -0.36 | -0.40 | -0.38 | -0.37 | -0.39 | -0.38 | -0.39 | -0.21 | |||||||||||
| Consensus Estimate | -0.24 | -0.26 | -0.25 | -0.26 | -0.31 | -0.28 | -0.30 | -0.29 | -0.35 | -0.38 | -0.36 | -0.35 | -0.36 | -0.36 | -0.37 | -0.20 |
Pull Wall Street consensus for Roivant Sciences Ltd. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ROIV&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ROIV", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ROIV&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();